wechat public accounts

Address: Building F2, No. 88, Kechuang 6th Street, Beijing Economic Development Zone

Tel: +86  010-56315466

Fax: +86  010-56315314

E-mail: hr@jacobiopharma.com

             bd@jacobiopharma.com

 

 

百度地图API自定义地图

Copyright: JACOBIO PHARMACEUTICALS GROUP CO., LTD.   Beijing ICP preparation 17065868-1   

 

关于我们

NEW

NEW

JACOBIO announced the appointment of Dr. Jian Kang, as Vice President of the IP department

Page view
[Abstract]:
BEIJING, China, September 28, 2020 - Jacobio Pharmaceuticals Group Co., Ltd. announced the appointment of Dr. Jian Kang, as Vice President of the IP department.

  BEIJING, China, September 28, 2020 - Jacobio Pharmaceuticals Group Co., Ltd. announced the appointment of Dr. Jian Kang, as Vice President of the IP department.

Dr.Kang

  Dr. Kang will lead the IP department and responsible for all IP related work. She has been working in the patent profession for 16 years and was a litigation patent attorney recommended by the All-China Patent Agent Association. She focuses on patent protection in the field of life sciences, and has an insightful understanding as well as extensive work experience in patent mining and drafting, patent prosecution, patent litigation and enforcement, legal opinions, due diligence, patent licensing and M&A for innovative drugs and the related technical fields.

  Dr. Kang graduated from Peking Union Medical College with a doctorate degree in medicine. Prior to joining Jacobio, she led the practicing department of an internationally renowned IP firm and used to work as a senior patent counsel in a pharmaceutical MNC in China. Dr. Kang is qualified as both patent attorney and attorney-at-law in China.

  Yinxiang Wang, Ph.D., Jacobio’s CEO and Chairman said, “Dr.Kang’s breadth of experience and expertise, particularly inIP will be invaluable to our current and future needs. We look forward to advancing Jacobio’s capability in IP under his leadership and further strengthening our management team. I am very pleased to welcome Dr. Kang to our team in our growth”.